|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.14 USD | -0.40% |
|
+1.97% | -16.52% |
| Apr. 23 | BIONTECH : Gets a Neutral rating from Deutsche Bank | ZD |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
Ryvu Therapeutics S.A announced a private placement of ?20 million in an equity round of funding on November 30, 2022. The transaction include participation from BioNTech SE.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 88.14 USD | -0.40% | +1.97% | 21.33B | ||
| 49.75 PLN | -2.07% | -7.01% | 292M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -16.52% | 21.33B | |
| -1.77% | 105B | |
| +3.25% | 97.5B | |
| +1.86% | 22.19B | |
| -8.49% | 18.68B | |
| -42.33% | 16.6B | |
| -20.88% | 14.52B | |
| +5.03% | 14.09B | |
| +22.50% | 10.99B | |
| -23.92% | 8.63B |
BIONTECH SE 
